2022 Annual Meeting of the European Association for the Study of the Liver*

Download All
June 22-26, 2022; London, United Kingdom
Get expert insights on key viral hepatitis data presented at EASL 2022 and learn how these data on HBV, HCV, and HDV may change your practice.
Nancy Reau, MD

ClinicalThought

Read my take on which new viral hepatitis data from EASL 2022 are the most practice changing, including HBV novel therapeutics in development, therapeutic vaccination for HBV cure, emerging treatments for HDV, HCV care cascade, and the need for HCC monitoring post HCV cure.

Nancy Reau, MD Released: July 13, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings